Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone or olanzapine.
- 1 November 1998
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 20 (6) , 1203-1217
- https://doi.org/10.1016/s0149-2918(98)80116-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Olanzapine Versus Placebo and Haloperidol: Quality of Life and Efficacy Results of the North American Double-Blind TrialNeuropsychopharmacology, 1998
- Impact of risperidone on the use of mental health care resourcesPsychiatric Services, 1997
- Economic and Health State Utility Determinations for Schizophrenic Patients Treated With Risperidone or HaloperidolJournal of Clinical Psychopharmacology, 1997
- Extrapyramidal Symptoms in Patients Treated With RisperidoneJournal of Clinical Psychopharmacology, 1997
- Reduction of Healthcare Resource Utilisation and Costs Following the Use of Risperidone for Patients with Schizophrenia Previously Treated with Standard Antipsychotic TherapyClinical Drug Investigation, 1996
- Efficacy and safety of risperidone in the long-term treatment of patients with schizophreniaClinical Therapeutics, 1995
- Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus HaloperidolThe British Journal of Psychiatry, 1995
- Risperidone in the treatment of schizophreniaAmerican Journal of Psychiatry, 1994
- The economic burden of schizophreniaPsychiatric Bulletin, 1990
- Economic Costs of Schizophrenia: A Postdischarge StudyMedical Care, 1983